I joined Genentech in May 2007 to lead the Small Molecule Discovery Chemistry Department after 25 years at the Pfizer Ann Arbor site, the last seven as Vice President of Chemistry. I was attracted to Genentech because of its rich culture of scientific excellence and dedication to innovative, ground-breaking research driven by the needs of patients.

What I have seen at Genentech during my short tenure is a real commitment to discovering and developing therapies for difficult, life-threatening diseases where medical need is high and often patients are desperate for new medical advances. This commitment is a distinguishing feature that attracted me to Genentech.

• My Focus

  I'm inspired by all the patients who have benefited from the outstanding work we do in the biotechnology and pharmaceutical industry. And I've come to realize that patients are waiting, often desperately, for the hope brought by new drug therapies, and that our efforts really can make a difference in the lives of patients.

• Education
  • Pfizer Global Research and Development, Vice President, Chemistry – 2000-2007
  • Warner-Lambert/Parke-Davis Research Scientist, Research Scientist; Senior Director, Atherosclerosis, Inflammation and Exploratory Chemistry – 1982-1999
  • University of Rochester, Postdoctoral Fellow – 1981-1982
  • Iowa State University, Ph.D. – 1981
  • St. Joseph's College, B.S. – 1976
• Awards & Honors
  • Perkin Medal by the Society of Chemical Industry – 2013
  • Heroes of Chemistry Honoree – 2008
  • Pfizer Global Research and Development Achievement Award – 2006
  • Iowa State University Distinguished Alumni Award – 2005
  • Gustavus John Esselen Award for Chemistry in the Public Service – 2003
  • American Chemical Society Award for Creative Invention – 2003
  • New York Intellectual Property Law Association Inventor of the Year Award – 1999
  • Warner-Lambert Chairman's Distinguished Scientific Achievement Award for the Discovery and Developme – 1997